Real-time enrollment status for this triple negative breast cancer (tnbc) clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 10:08 PM UTC
| NCT Number | NCT07513311 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer (TNBC) |
| Phase | NA |
| Target Enrollment | 75 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of August 31, 2026: Clinical trial NCT07513311 is currently recruiting participants. This na study for triple negative breast cancer (tnbc) is actively seeking new participants at 1 location across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07513311 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07513311 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.